
Padmavathi Baskar
Examiner (ID: 13817, Phone: (571)272-0853 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1641, 1645 |
| Total Applications | 1590 |
| Issued Applications | 1047 |
| Pending Applications | 159 |
| Abandoned Applications | 391 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17221714
[patent_doc_number] => 11174204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Lactic acid bacteria, and feed, fertilizer, and viable bacterial preparation containing said lactic acid bacteria
[patent_app_type] => utility
[patent_app_number] => 16/332977
[patent_app_country] => US
[patent_app_date] => 2017-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2984
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332977 | Lactic acid bacteria, and feed, fertilizer, and viable bacterial preparation containing said lactic acid bacteria | Sep 11, 2017 | Issued |
Array
(
[id] => 13717163
[patent_doc_number] => 20170369536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => Compositions and Methods Related to Protein A (SpA) Variants
[patent_app_type] => utility
[patent_app_number] => 15/702037
[patent_app_country] => US
[patent_app_date] => 2017-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15702037
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/702037 | Compositions and methods related to Protein A (SpA) Variants | Sep 11, 2017 | Issued |
Array
(
[id] => 17095409
[patent_doc_number] => 20210283200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => SALT-TOLERANT LACTOBACILLUS, METHOD OF CULTURING SALT-TOLERANT LACTOBACILLUS, AND IMMUNOSTIMULANT
[patent_app_type] => utility
[patent_app_number] => 16/332577
[patent_app_country] => US
[patent_app_date] => 2017-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332577 | Salt-tolerant | Sep 11, 2017 | Issued |
Array
(
[id] => 14501225
[patent_doc_number] => 20190194267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => MUCOADHESIVE MICROORGANISM
[patent_app_type] => utility
[patent_app_number] => 16/331660
[patent_app_country] => US
[patent_app_date] => 2017-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331660
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/331660 | Mucoadhesive microorganism | Sep 10, 2017 | Issued |
Array
(
[id] => 12219211
[patent_doc_number] => 20180057571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/699345
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14634
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699345
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/699345 | Methods of treating and preventing | Sep 7, 2017 | Issued |
Array
(
[id] => 12126266
[patent_doc_number] => 20180009852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/698434
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19368
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698434
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/698434 | Immunogenic bacterial vesicles with outer membrane proteins | Sep 6, 2017 | Issued |
Array
(
[id] => 16492636
[patent_doc_number] => 10858663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Genetically modified bacteria stably expressing IL-10 and insulin
[patent_app_type] => utility
[patent_app_number] => 16/329321
[patent_app_country] => US
[patent_app_date] => 2017-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 44
[patent_no_of_words] => 30793
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329321
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/329321 | Genetically modified bacteria stably expressing IL-10 and insulin | Sep 1, 2017 | Issued |
Array
(
[id] => 13970477
[patent_doc_number] => 10214581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Compositions and methods for treating and preventing
[patent_app_type] => utility
[patent_app_number] => 15/680533
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 13
[patent_no_of_words] => 11194
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15680533
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/680533 | Compositions and methods for treating and preventing | Aug 17, 2017 | Issued |
Array
(
[id] => 12091314
[patent_doc_number] => 20170348407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'STAPHYLOCOCCUS AUREUS PROTEINS AND NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 15/679910
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20789
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679910
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/679910 | None | Aug 16, 2017 | Issued |
Array
(
[id] => 15006263
[patent_doc_number] => 10449237
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-10-22
[patent_title] => Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
[patent_app_type] => utility
[patent_app_number] => 15/679874
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 11
[patent_no_of_words] => 19274
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679874
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/679874 | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity | Aug 16, 2017 | Issued |
Array
(
[id] => 12979729
[patent_doc_number] => 20170342114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => NOVEL RHTB PROTEIN VARIANTS AND THE METHOD OF PRODUCING O-PHOSPHOSERINE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/679671
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679671
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/679671 | RhtB protein variants and the method of producing O-phosphoserine using the same | Aug 16, 2017 | Issued |
Array
(
[id] => 13222829
[patent_doc_number] => 10125179
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-13
[patent_title] => RhtB protein variants and the method of producing O-phosphoserine using the same
[patent_app_type] => utility
[patent_app_number] => 15/679679
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5958
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/679679 | RhtB protein variants and the method of producing O-phosphoserine using the same | Aug 16, 2017 | Issued |
Array
(
[id] => 13354747
[patent_doc_number] => 20180228913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => PROTOZOAN VARIANT-SPECIFIC SURFACE PROTEINS (VSP) AS CARRIERS FOR ORAL DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 15/673037
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673037
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673037 | PROTOZOAN VARIANT-SPECIFIC SURFACE PROTEINS (VSP) AS CARRIERS FOR ORAL DRUG DELIVERY | Aug 8, 2017 | Abandoned |
Array
(
[id] => 15225145
[patent_doc_number] => 10500277
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma
[patent_app_type] => utility
[patent_app_number] => 15/663562
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15162
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15663562
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/663562 | Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma | Jul 27, 2017 | Issued |
Array
(
[id] => 13942523
[patent_doc_number] => 10207006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Oligosaccharide conjugates and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/662699
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 41549
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15662699
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/662699 | Oligosaccharide conjugates and methods of use | Jul 27, 2017 | Issued |
Array
(
[id] => 16275584
[patent_doc_number] => 10758591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Compositions and methods for treating clostridium difficile infection
[patent_app_type] => utility
[patent_app_number] => 16/317887
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 27709
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317887
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317887 | Compositions and methods for treating clostridium difficile infection | Jul 24, 2017 | Issued |
Array
(
[id] => 15290805
[patent_doc_number] => 20190388538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => INCREASED FERTILITY IN BOVINE SPECIES
[patent_app_type] => utility
[patent_app_number] => 16/320256
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320256
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320256 | Increased fertility in bovine species | Jul 24, 2017 | Issued |
Array
(
[id] => 14029547
[patent_doc_number] => 10226505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
[patent_app_type] => utility
[patent_app_number] => 15/656758
[patent_app_country] => US
[patent_app_date] => 2017-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 31
[patent_no_of_words] => 29227
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15656758
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/656758 | Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens | Jul 20, 2017 | Issued |
Array
(
[id] => 12126307
[patent_doc_number] => 20180009892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'ANTI-ROR1 ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/654514
[patent_app_country] => US
[patent_app_date] => 2017-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 26911
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15654514
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/654514 | ANTI-ROR1 ANTIBODIES | Jul 18, 2017 | Abandoned |
Array
(
[id] => 16589322
[patent_doc_number] => 10898564
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine
[patent_app_type] => utility
[patent_app_number] => 16/318365
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 25056
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318365
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318365 | Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine | Jul 17, 2017 | Issued |